Bio-Connect

Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266)

A2697
Selleck Chemicals
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Selleck Chemicals
  • Product Name
    Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266)
  • Delivery Days Customer
    9
  • Certification
    Research Use Only
  • Estimated Purity
    ...
  • Scientific Description
    Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) is a humanized monoclonal antibody directed against the tumor necrosis factor-like weak inducer of apoptosis receptor (TWEAKR) with potential antineoplastic, immunomodulating and antiangiogenic activities. MW : 150 kD.
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203